The Biomarkers That Matter for Weight Loss

## Beyond the Scale The scale tells you one number: your total body weight. It does not distinguish between fat loss and muscle loss. It does not tell you how your metabolic health is improving, whether your liver is responding to reduced visceral fat, or how your hormonal profile is shifting. Lab biomarkers fill in these gaps, giving you and your physician a much richer picture of what is actually happening inside your body. For members on GLP-1 treatment or any structured weight loss program, periodic lab work is not just a safety check. It is a roadmap. ## Metabolic Health Markers ### Fasting Glucose and HbA1c These two markers are foundational for anyone pursuing weight loss, particularly members with prediabetes or insulin resistance. Fasting glucose measures your blood sugar at a single point in time, while HbA1c reflects your average blood sugar over two to three months. GLP-1 medications improve both markers, often significantly. Many members who start treatment with prediabetic HbA1c levels (5.7 to 6.4 percent) see normalization within three to six months. This improvement in glucose regulation reduces future diabetes risk and reflects genuine metabolic healing, not just weight loss. ### Fasting Insulin While glucose tells you the end result of blood sugar regulation, fasting insulin tells you how hard your body is working to achieve it. Elevated fasting insulin (hyperinsulinemia) is an early marker of insulin resistance, often appearing years before glucose levels become abnormal. As body fat decreases (particularly visceral fat around the organs), insulin sensitivity improves and fasting insulin levels decline. Tracking this marker over time provides early evidence that your metabolic health is improving at a fundamental level. ### HOMA-IR HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated from your fasting glucose and fasting insulin values. It provides a single number that estimates your degree of insulin resistance. A HOMA-IR below 1.0 is considered optimal. Values above 2.0 suggest significant insulin resistance. This is a particularly useful marker for members who have "normal" fasting glucose but elevated insulin, a common pattern in early metabolic dysfunction that standard glucose testing misses. ## Liver Health ### ALT and AST Non-alcoholic fatty liver disease (NAFLD) is present in an estimated 25 to 30 percent of adults and is strongly associated with obesity and insulin resistance. ALT and AST are liver enzymes that become elevated when liver cells are damaged or inflamed. Weight loss, particularly the reduction of visceral fat, consistently improves liver enzyme levels. Many members with elevated ALT at baseline see normalization within three to six months of treatment. This is a meaningful health outcome that goes well beyond cosmetic improvement. ### GGT Gamma-glutamyl transferase (GGT) is another liver enzyme that is sensitive to liver fat accumulation and alcohol-related liver stress. It is a useful complement to ALT and AST and can provide earlier detection of liver improvement during weight loss. ## Cardiovascular Risk Markers ### Lipid Panel Weight loss, particularly fat loss, typically improves all components of the lipid panel. LDL cholesterol tends to decrease, HDL cholesterol tends to increase, and triglycerides often show the most dramatic improvement. Some members see triglyceride reductions of 30 percent or more within the first six months of GLP-1 treatment. These lipid improvements translate to measurable reductions in cardiovascular risk, which is significant because cardiovascular disease remains the leading cause of death globally. ### hs-CRP (High-Sensitivity C-Reactive Protein) hs-CRP is a marker of systemic inflammation. Chronic, low-grade inflammation is a feature of obesity and is linked to cardiovascular disease, type 2 diabetes, and multiple other conditions. Weight loss reduces hs-CRP levels. Monitoring this marker over time provides evidence that your body's inflammatory burden is decreasing, which has broad implications for long-term health. A value below 1.0 mg/L is considered low cardiovascular risk, 1.0 to 3.0 is moderate, and above 3.0 is elevated. ## Hormonal Markers ### Testosterone (in Men) Obesity is one of the most common causes of low testosterone in men. Excess body fat increases aromatase activity, the enzyme that converts testosterone to estrogen, resulting in lower testosterone and higher estradiol levels. This creates a negative cycle: low testosterone promotes fat storage, and increased fat further suppresses testosterone. Weight loss, particularly combined with resistance training, can significantly increase testosterone levels. Some members see increases of 100 ng/dL or more with substantial weight loss, sometimes enough to resolve low-T symptoms without requiring hormone therapy. ### Thyroid Function (TSH, Free T4) Thyroid function should be assessed at baseline for anyone beginning a weight loss program. Hypothyroidism (underactive thyroid) causes weight gain, fatigue, and metabolic slowing that can interfere with treatment effectiveness. If thyroid dysfunction is present, addressing it is essential for optimal weight loss outcomes. ## Kidney Function ### BUN and Creatinine Adequate hydration is important during GLP-1 treatment, as reduced food intake can also reduce water intake (since food provides a significant portion of daily water). Kidney function markers should be monitored to ensure that the kidneys are functioning well and that hydration is adequate. ## How Often Should You Test? For members on GLP-1 treatment, a reasonable testing schedule includes a baseline panel before or shortly after starting treatment, a follow-up at three months to assess early response, subsequent testing every three to six months during active weight loss, and annual monitoring once weight has stabilized. Your Clyne physician will recommend a testing schedule based on your health profile and treatment plan. Results are available through your dashboard, with trends tracked over time so you can see your progress in real numbers. ## What the Numbers Mean for You Lab improvements during weight loss are not abstract. Lower fasting glucose means reduced diabetes risk. Improved lipids mean a healthier cardiovascular system. Normalized liver enzymes mean your liver is recovering. Higher testosterone means better energy, mood, and body composition. These are the outcomes that matter most for long-term health, and they are often well underway before you reach your goal weight. The journey is producing benefits from the very beginning.